Literature DB >> 2116224

Endogenous and exogenous polyamines in support of tumor growth.

N Seiler1, S Sarhan, C Grauffel, R Jones, B Knödgen, J P Moulinoux.   

Abstract

The combination of inhibitors of ornithine decarboxylase and polyamine oxidase and of antibiotics suitable for the (partial) decontamination of the gastrointestinal tract with a polyamine-deficient diet reduced the growth rate of Lewis lung carcinoma by more than 80%. The formation of lung metastases was prevented by 70 to 100%, depending on the treatment. The reduction of tumor growth was accompanied by a decrease of tissue polyamine concentrations, a reduced rate of tumor cell proliferation, and protein synthesis. The comparison of the ornithine decarboxylase inhibitors Eflornithine [D,L-2-(difluoromethyl)ornithine] and (E)-2-(fluoromethyl)dehydroornithine ethylester confirmed the greater in vivo potency of the latter compound. Our method of growth inhibition by systematic polyamine deprivation is not tumor specific, but presumably generally applicable to rapid growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116224

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development.

Authors:  C Löser; A Eisel; D Harms; U R Fölsch
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

2.  Substrate protection against inactivation of the mammalian polyamine-transport system by 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide.

Authors:  K Torossian; M Audette; R Poulin
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.

Authors:  B Cipolla; Y Blanchard; L Chamaillard; V Quemener; F Guillé; R Havouis; J P Moulinoux
Journal:  Urol Res       Date:  1996

4.  Enhanced uptake of [3H] spermidine by 9L rat brain tumors after direct intratumoral infusion of inhibitors of enzymes of the polyamine biosynthetic pathway.

Authors:  E S Redgate; A G Grudziak; M Deutsch; S S Boggs
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

5.  Polyamine oxidase activity in sera of depressed and schizophrenic patients after ECT treatment.

Authors:  K A Dahel; N M Al-Saffar; K A Flayeh
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

6.  Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.

Authors:  Natalia A Ignatenko; David G Besselsen; Upal K Basu Roy; David E Stringer; Karen A Blohm-Mangone; Jose L Padilla-Torres; Jose M Guillen-R; Eugene W Gerner
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

7.  Decreased hyperammonaemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase.

Authors:  N Seiler; C Grauffel; G Daune-Anglard; S Sarhan; B Knödgen
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.

Authors:  Mark R Burns; Gerard F Graminski; Reitha S Weeks; Yan Chen; Thomas G O'Brien
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

Review 9.  Polyamines in brain tumor therapy.

Authors:  E S Redgate; S Boggs; A Grudziak; M Deutsch
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  A putrescine-anthracene conjugate: a paradigm for selective drug delivery.

Authors:  Andrew J Palmer; Radiah A Ghani; Navneet Kaur; Otto Phanstiel; Heather M Wallace
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.